EPISODE · Aug 15, 2019 · 10 MIN

Dolutegravir

from Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Dolutegravir is an integrase inhibitor that is used in the management of HIV infection/ Carbamazepine along with other enzyme inducers can substantially lower the concentrations of dolutegravir. Dolutegravir can potentially increase blood sugars, this should be closely monitored in our patients with diabetes. CNS adverse effects like insomnia and dizziness can happen with dolutegravir. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Episode metadata supplied by the publisher feed · Published Aug 15, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Dolutegravir

0:00 10:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Real Life Pharmacology - Pharmacology Education for Health Care Professionals?

This episode is 10 minutes long.

When was this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode published?

This episode was published on August 15, 2019.

Can I download this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!